In Ewing sarcoma, the expression of CCR5-ligand, CCL5, is positively related to the number of infiltrating CD8+ T-lymphocyte and patients with high numbers of infiltrating T-lymphocytes have an overall survival advantage (Berghuis et al., 2011). Here, CCL5 is linked to Ewing sarcoma.